Alveolar Soft Part Sarcoma (also called Alveolar Soft-Part Sarcoma) is a rare type of cancer. It starts in the connective tissues, often in the muscles or bones. It tends to grow slowly but can spread to other parts of the body, like the lungs or brain. It usually affects adults, but can occur in children.
Every report comes from a Lived member, sent anonymously.
Have you had Surgery for Alveolar Soft Part Sarcoma?
Alveolar soft part sarcoma (ASPS) is a very rare cancer that grows in the body's soft tissues, most often deep in the muscles of the thigh or buttock. In children it more often appears in the head and neck, such as the tongue or the area around the eye. It is one of the rarest sarcomas, with roughly 80 people diagnosed each year in the United States, and it mostly affects teenagers and young adults. ASPS behaves in an unusual way. It grows slowly and usually starts as a painless lump, so it can go unnoticed for a long time. Yet it builds its own dense network of blood vessels, which lets cancer cells travel early. By the time it is found, it has often already spread, most commonly to the lungs and less often to bone or the brain. That combination of slow growth and early spread shapes how it is diagnosed, treated and followed over the years.
ASPS is driven by a specific change inside the tumor cells. Two pieces of chromosome break and rejoin in the wrong place, fusing a gene called TFE3 to a gene called ASPSCR1. The fused gene makes the cells grow and behave abnormally. This change happens in the tumor itself during a person's life; it is not inherited, and ASPS is not known to run in families. Researchers have not found any lifestyle habit, exposure or earlier illness that causes the chromosome change. Nothing a person did or failed to do is known to bring on this cancer.
Because the lump is usually painless and slow-growing, it is often first noticed simply because it is there or getting larger. An MRI or CT scan shows the tumor's size and position and helps plan a biopsy, in which a needle takes a small sample of tissue. A pathologist examines the cells under a microscope and can confirm ASPS with stains or genetic tests that detect the TFE3 gene fusion. Because ASPS is so rare, having the sample reviewed by a pathologist experienced with sarcomas matters. Once ASPS is confirmed, the next step is staging: finding out whether and where it has spread. This usually means a CT scan of the chest to look for lung spots and imaging of the brain, because ASPS spreads to the brain more often than other sarcomas, sometimes before it causes any symptoms. Other scans may look for spread to bone.
Treatment depends on where the tumor is and whether it has spread, and it is best planned at a center that treats many sarcomas. When the cancer is confined to one place, surgery to remove the whole tumor with a rim of healthy tissue around it is the main treatment and can cure some people. Radiation therapy is sometimes added around the time of surgery, usually when the edges of the removed tissue are close to the tumor or when the tumor cannot be fully removed. Its benefit after a clean removal is less certain. Standard chemotherapy, which helps many other sarcomas, generally does not work for ASPS. For cancer that has spread or cannot be removed, the main options are newer drugs. Atezolizumab (Tecentriq) is an immunotherapy, a medicine that releases a brake on the immune system so it can attack the cancer. It is FDA approved for ASPS that has spread or cannot be removed, in adults and children 2 and older, and is given by infusion every few weeks. In the main trial, tumors shrank in about a third of people, and when they did, the response often lasted around three years. Because it stimulates the immune system, it can cause inflammation in almost any organ, such as the lungs, bowel, liver or hormone glands, which can be serious and needs regular blood tests and prompt attention to new symptoms. Targeted pills that block the blood vessel growth ASPS depends on, such as pazopanib (Votrient) and sunitinib (Sutent), are another option and can slow the cancer or shrink it for a time. Other immunotherapy drugs and combinations are being studied. Surgery or focused radiation may also be used for a small number of spots in the lungs or brain. Clinical trials are an important route to treatment for this rare cancer.
Because ASPS grows slowly, many people live for years, even when the cancer has spread, though the course differs widely from person to person. Outlook depends mainly on whether the cancer has spread, where the tumor is, its size and how completely it was removed. Children with ASPS that has not spread tend to do better than adults. Older survival figures, drawn from small groups, suggest that most people whose cancer had not spread were alive five years later, while results were lower and more varied when it had spread. Those numbers predate newer drugs, so they may not reflect what is possible today. Even after successful surgery, ASPS can appear in the lungs or elsewhere years later, so follow-up continues for a long time with regular chest scans, often brain imaging, and checks of the original site. For people living with spread disease, treatment may continue for long periods, with scans every few months to see whether the cancer is stable, shrinking or growing. On immunotherapy, tumors sometimes look larger on early scans before shrinking, so a single scan is not always the final word. Many people keep working, studying and following their usual routines during treatment, while others need time to recover from surgery or manage side effects.
See a doctor about a lump deep in the thigh, buttock or other soft tissue that persists or grows, even if it does not hurt, and ask whether imaging is needed before any surgery to remove it. If you have ASPS, contact your care team promptly about a new cough, coughing up blood or growing shortness of breath, new or worsening headaches, or changes in vision, speech, strength or balance, since these can be signs of spread to the lungs or brain. During immunotherapy, report new symptoms such as diarrhea, belly pain, a cough, a rash, yellowing of the skin or eyes, or unusual tiredness right away, because immune side effects are easier to treat early.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Alveolar Soft Part Sarcoma is like, what's helped you, or ask the community a question.